sheng jiang
China Pharmaceutical University
Nanjing, China
Review Editor
Anti-Cancer Drugs
Editors
- Frontiers in Drug Discovery
- Anti-Cancer Drugs
- Editorial board
Type at least 3 characters
Editors
Shape the future of research in your field
Join the board
Review Editors
zhong-xing jiang
Innovation Academy for Precision Measurement Science and Technology, Chinese Academy of Sciences (CAS)
Wuhan, China
Review Editor
Anti-Cancer Drugs
lucía jiménez
Sols-Morreale Biomedical Research Institute (IIBM), Faculty of Medicine, Autonomous University of Madrid
Madrid, Spain
Review Editor
Anti-Cancer Drugs
silvia jiménez-morales
Laboratorio de Innovación y Medicina de Precisión, Núcleo A, Instituto Nacional de Medicina Genómica
Mexico, Mexico
Review Editor
Anti-Cancer Drugs
seong jong kim
USDA Agricultural Research Service
Oxford, United States
Review Editor
Anti-Cancer Drugs
dhiraj kumar
University of Texas MD Anderson Cancer Center
Houston, United States
Review Editor
Anti-Cancer Drugs
dr. prem prakash kushwaha
School of Medicine, Case Western Reserve University
Cleveland, United States
Review Editor
Anti-Cancer Drugs
guo-bo li
Sichuan University
Chengdu, China
Review Editor
Anti-Cancer Drugs
shiliang li
East China University of Science and Technology
Shanghai, China
Review Editor
Anti-Cancer Drugs
zhengqiu li
Jinan University
Guangzhou, China
Review Editor
Anti-Cancer Drugs
wukun liu
Nanjing University of Chinese Medicine
Nanjing, China
Review Editor
Anti-Cancer Drugs
xin hua liu
Anhui Medical University
Hefei, China
Review Editor
Anti-Cancer Drugs
eduardo lópez-urrutia
National Autonomous University of Mexico
México City, Mexico
Review Editor
Anti-Cancer Drugs
rhanye mac guad
Universiti Malaysia Sabah
Kota Kinabalu, Malaysia
Review Editor
Anti-Cancer Drugs
miguel machuqueiro
University of Lisbon
Lisbon, Portugal
Review Editor
Anti-Cancer Drugs
rishabha malviya
School of Medical and Allied Sciences, Galgotias University
Greater Noida, India
Review Editor
Anti-Cancer Drugs